Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational development of a HIV-1 gene therapy vector.

D S Anson1,2, M Fuller1

  • 1Department of Chemical Pathology, Women's and Children's Hospital, 72 King William Road, North Adelaide, South Australia, Australia, 5006.

The Journal of Gene Medicine
|October 9, 2003
PubMed
Summary

Researchers optimized human immunodeficiency virus type 1 (HIV-1) vectors for gene transfer by identifying key cis elements that enhance vector production and safety. This work improves HIV-1 vector efficiency and safety profiles for gene therapy applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrathecal morphine 100 µg versus 150 µg for post-cesarean delivery analgesia: a retrospective cohort study (2020-2022).

International journal of obstetric anesthesia·2025
Same author

AI-augmented vs. conventional cardiac POCUS training: a pilot study among obstetric anesthesiologists.

International journal of obstetric anesthesia·2024
Same author

Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.

Orphanet journal of rare diseases·2022
Same author

Intrathecal bupivacaine versus chloroprocaine for transvaginal cervical cerclage placement: a retrospective cohort study.

International journal of obstetric anesthesia·2022
Same author

Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania.

Substance abuse·2022
Same author

Frailty Is Associated with Impaired Diabetic Foot Ulcer Healing and All-Cause Re-Hospitalization.

The journal of nutrition, health & aging·2022

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Human immunodeficiency virus type 1 (HIV-1) is a promising basis for gene transfer vectors due to its ability to transduce non-cycling cells.
  • Understanding the impact of viral cis elements on vector function is crucial for maximizing HIV-1 vector potential.

Purpose of the Study:

  • To systematically evaluate the effects of various HIV-1 cis sequence elements on gene vector production efficiency (titer and infectivity).
  • To assess the safety of different vector designs by measuring the potential for inadvertent transfer of the gagpol gene.
  • To identify and construct an optimized HIV-1 vector with improved characteristics.

Main Methods:

  • Systematic evaluation of cis elements from the HIV-1 YU-2 genome.
  • Assessment of vector production efficiency, including titer and infectivity.

Related Experiment Videos

  • Analysis of gagpol gene transfer to transduced cells as a safety measure.
  • RNA analysis to investigate the role of the Rev/RRE system.

    • Main Results:

    • Specific sequences, including those from the 5' gag, 5' and 3' env genes, and the polypurine tract, increased vector titer.
    • Substitution or deletion of the HIV-1 Rev-responsive element (RRE) significantly reduced vector titers.
    • RNA analysis indicated the Rev/RRE system has functions beyond nuclear export.
    • An optimal vector construct with enhanced safety characteristics was identified.

    Conclusions:

    • An optimized HIV-1 vector was constructed, demonstrating superior efficiency and safety compared to the widely used pHR' vector.
    • The study delineates critical cis elements for enhancing HIV-1 vector performance.
    • Findings contribute to the development of safer and more effective gene transfer vectors.